Cerebras Systems (CBRS) is set to report earnings on Nov. 12, with Wall Street analysts expecting a loss of $0.13 in earnings per share (EPS) on average. Ahead of the print, options traders appear to be positioning for a rally after what has been a difficult stretch for CBRS shares.
That said, technical indicators suggests continued pressure on Cerebras that’s already down about 60% versus its year-to-date high.
Barchart data shows a put-to-call ratio of 0.5x on CBRS options contracts expiring Nov. 20. In simple terms, that suggests traders are betting twice as much on call options as put options, indicating a stronger preference for bullish wagers than downside protection.
The derivatives market is also implying a potential move toward $106.79, which sits roughly 14% above current trading levels.
While options pricing does not predict future stock performance, it can provide a useful snapshot of investor expectations heading into a major catalyst such as earnings.
On the flip side, however, Cerebras stock is currently trading below its key moving averages (MAs), with an RSI in the early 30s indicating bears remain firmly in control.
The longer-term growth narrative for CBRS stock remains tied to the accelerating AI infrastructure buildout.Earlier this year, the company announced a multiyear agreement with OpenAI to deploy up to 750 megawatts of AI inference capacity, a deal valued at as much as $20 billion.
Cerebras has also expanded its partnerships with major tech players, including Oracle (ORCL), while continuing to scale its cloud and inference businesses.
All in all, the bull case rests on the Nasdaq-listed firm’s ability to convert a growing backlog of AI demand into sustained revenue growth. If management delivers encouraging commentary on execution, customer adoption, and future capacity deployments when it reports earnings, CBRS could find fresh momentum in the weeks ahead.
Wall Street also remains bullish on Cerebras shares heading into the fiscal Q3 print. The consensus rating on CBRS remains at “Strong Buy,” with the mean price target of roughly $241 indicating potential upside of a whopping 165% from here.